The Rhino Health Platform improves AI-based healthcare solutions by providing access to a large, continually updated, distributed dataset from a diverse group of patients, powering models that deliver consistent results and improve the standard of care. Ultimately, this improves health outcomes for large populations of patients and creates equitable access to advanced AI-based diagnostics and treatment pathways.
For hospitals and health systems, Rhino Health makes it easy to collaborate in data-driven studies and AI research initiatives as well as with companies developing healthcare AI solutions. Patient privacy is always protected, as data never leaves the system of origin. For the companies developing AI-based medical devices and software applications, Rhino Health provides access to an unprecedented quantity and quality of clinically relevant real-world patient data.
Utilizing a Federated Learning (FL) approach, Rhino Health eliminates the complexity, expense and risk of moving and managing huge volumes of data. An AI developer’s model is applied to patient data where it lives. With this approach, AI models quickly and continuously improve – learning from each new dataset and applying those learnings to the next. This accelerates creation and training of more accurate AI models that work consistently across different patient populations, which leads to more widespread adoption of advanced healthcare solutions.
Headquartered in Cambridge, MA, with an R&D Center in Tel Aviv, Israel, Rhino Health is a growing team of healthcare and technology experts committed to accelerating creation and adoption of AI-based healthcare solutions for increasingly diverse patient populations. We are backed by a syndicate of investors including LionBird Ventures, Arkin Holdings and several angel investors who bring extensive experience across healthcare, technology and biopharma.